Ask what the proof shows.

As of September 2026, FDA describes as false or misleading a claim that studies in people prove the same results from a medicine made to order and an approved medicine. FDA on claims about compounded products ↗

This warning concerns what the seller claims to have proved. It does not tell you what result you would get. Ask for evidence about the exact medicine being offered.

Ask whether the cited study used the finished product, the same ingredient, or something else. Ask whether the claim concerns your intended use. A link to a study is the start of that check.

If you cannot tell what a study actually tested, bring it to the clinician. Request the finding in plain words and the part that remains uncertain.

BPC-157 is one peptide named in FDA’s safety concerns. As of September 2026, FDA has too little information from use in people to know whether BPC-157 would harm them. FDA’s account of missing human information ↗

The recorded information does not tell us what benefit to expect or which form a seller would offer. Ask: “What problem do you claim this helps, and would it be a shot, tablet or something else?” Then ask what studies in people support that exact use and form.

The FTC says no government agency approves health adverts before they appear. The FTC on health claims ↗

The FTC is the Federal Trade Commission, which deals with consumer protection. A polished advert is still an advert. Ask for the study behind a result claim rather than relying on its presentation.

Write down the answer you receive. If the reply changes the product or the goal, bring the conversation back to the treatment actually proposed for you.